Bank of America’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128 | Buy |
73
+6
| +9% | +$11 | ﹤0.01% | 6886 |
|
|
2025
Q1 | $91 | Buy |
67
+3
| +5% | +$4 | ﹤0.01% | 6794 |
|
|
2024
Q4 | $243 | Sell |
64
-33
| -34% | -$125 | ﹤0.01% | 6626 |
|
|
2024
Q3 | $262 | Sell |
97
-68
| -41% | -$184 | ﹤0.01% | 6581 |
|
|
2024
Q2 | $511 | Buy |
+165
| New | +$511 | ﹤0.01% | 6462 |
|
|
2024
Q1 | – | Sell |
-5
| Closed | -$38 | – | 7015 |
|
|
2023
Q4 | $38 | Buy |
+5
| New | +$38 | ﹤0.01% | 6585 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$22 | – | 7211 |
|
|
2022
Q4 | $22 | Sell |
4
-43
| -91% | -$237 | ﹤0.01% | 7143 |
|
|
2022
Q3 | $0 | Sell |
47
-31
| -40% | – | ﹤0.01% | 7141 |
|
|
2022
Q2 | $1K | Sell |
78
-200
| -72% | -$2.56K | ﹤0.01% | 7039 |
|
|
2022
Q1 | $10K | Buy |
278
+61
| +28% | +$2.19K | ﹤0.01% | 6935 |
|
|
2021
Q4 | $16K | Buy |
+217
| New | +$16K | ﹤0.01% | 6717 |
|